pH‐Sensitive Metal–Organic Frameworks for the Improved Inhibition of HepG2 Cell via Folate Receptor‐Mediated Targeting and Cascaded CDT Effect
Advanced Healthcare Materials · 2026-03 · 15 (11)
DOI: 10.1002/adhm.202504093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.11.2025. Verfasst von Chen Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Folate Receptors, GPI-Anchored. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin, Special Project for Technological Innovation in New Productive Forces of Modern Chinese Medicines, Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
Metal–organic frameworks (MOFs) have great potential for the development of targeted drug delivery systems (DDSs) to improve the effectiveness of inhibiting HepG2 cells. Herein, inspired by the solvothermal synthesis method and the concept of designable assembly, MOF (UiO‐66‐NH 2 ) is first doped by Fe‐Cu NPs to form Fe‐Cu@MOF and further modified with polydopamine (PDA) and folic acid (FA) to obtain Fe‐Cu@MOF‐PDA‐FA for the loading of resveratrol (RES). The Fe‐Cu@MOF‐PDA‐FA has desirable drug loading efficiency and excellent pH‐responsive release of RES. In vitro cellular experiments and 3D hepatoma cell microspheres model, the Fe‐Cu@MOF‐PDA‐FA not only showed low cytotoxicity but also post‐drug has a good inhibitory effect on HepG2. In addition, Fe‐Cu@MOF‐PDA‐FA could achieve good tumor penetration via FR‐mediated endocytosis, while showing good anticancer cellular activity and the ability to promote reactive oxygen species (ROS) generation. Therefore, RES@Fe‐Cu@MOF‐PDA‐FA has promising applications as pH‐responsive DDS in combination with chemodynamic therapy (CDT) for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
- Haihe Laboratory of Modern Chinese Medicine, Tianjin, P. R. China.
- State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
- South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, SA, Australia.
- Analytical Instrumentation Centre, Tianjin University, Tianjin, P. R. China.
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
ORCID-Profile: Fei Tian
Förderung
- Natural Science Foundation of Tianjin
- Special Project for Technological Innovation in New Productive Forces of Modern Chinese Medicines
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Zhang, C., Pu, X., Teng, G., Li, F., Bai, H., Lin, K., Wang, Y., Hao, J., Yang, J., & Tian, F. (2026). pH‐Sensitive Metal–Organic Frameworks for the Improved Inhibition of HepG2 Cell via Folate Receptor‐Mediated Targeting and Cascaded CDT Effect. Advanced Healthcare Materials, 15(11). https://doi.org/10.1002/adhm.202504093
Vancouver
Zhang C, Pu X, Teng G, Li F, Bai H, Lin K, et al. pH‐Sensitive Metal–Organic Frameworks for the Improved Inhibition of HepG2 Cell via Folate Receptor‐Mediated Targeting and Cascaded CDT Effect. Advanced Healthcare Materials. 2026;15(11). doi:10.1002/adhm.202504093
BibTeX
@article{Zhang2026,
author = {Zhang, Chen and Pu, Xueyu and Teng, Guohua and Li, Fuyi and Bai, Hezhao and Lin, Kui and Wang, Yi and Hao, Jia and Yang, Jian and Tian, Fei},
title = {pH‐Sensitive Metal–Organic Frameworks for the Improved Inhibition of HepG2 Cell via Folate Receptor‐Mediated Targeting and Cascaded CDT Effect},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/adhm.202504093}
}
EUVIMED